What is AirMid Critical Care Products?
AirMid Critical Care Products, Inc. operates at the intersection of medical technology and respiratory care, specializing in the development of advanced volume-control devices. The company's flagship innovation, the Volume Controlled Manual Ventilator (VCMV), addresses critical inefficiencies in traditional bag-type ventilators by ensuring consistent tidal volumes. By mitigating the risks of barotrauma and lung injury, AirMid provides healthcare professionals with a more reliable, data-backed tool for emergency resuscitation and patient stabilization. The company is currently transitioning from a development-focused entity to a market-scaling organization, leveraging its technological moat to modernize manual ventilation practices across global clinical settings.
How much funding has AirMid Critical Care Products raised?
AirMid Critical Care Products has raised a total of $103K across 1 funding round:
Debt
$103K
Debt (2026): $103K, investors not publicly disclosed
Key Investors in AirMid Critical Care Products
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for AirMid Critical Care Products?
With the infusion of this latest capital, AirMid Critical Care Products is poised to scale its manufacturing capabilities and expand its footprint in high-acuity care environments. The strategic roadmap focuses on deepening market penetration for the VCMV platform while investing in clinical validation studies to further solidify its position as a leader in respiratory safety. As the company moves through this late-stage financing cycle, the primary objective remains the widespread adoption of its precision-based resuscitation tools, ultimately aiming to reduce variability in patient outcomes and establish a new benchmark for manual ventilation safety in hospitals and emergency medical services worldwide.
See full AirMid Critical Care Products company page
